SR One Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 211
  • Portfolio
  • 36
  • Exits
  • 115
Exits

SR One General Information

Description

Founded in 1985, SR One is the corporate venture capital arm of GlaxoSmithKline based in Cambridge, Massachusetts. The firm prefers to invest in the life science, biotechnology, healthcare, medical devices, and information technology sectors.

Contact Information

Website
Year Founded
1985
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Accelerator/Incubator
Venture Capital
Primary Office
  • 161 Washington Street, Suite 500
  • Eight Tower Bridge, Conshohocken
  • Philadelphia, PA 19428
  • United States

SR One Investments (211)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Decibel Therapeutics 09-Nov-2020 Later Stage VC 0000 Drug Discovery Generating Revenue
0000000000 21-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1
0000000 0000000000 16-Sep-2020 00000 00000 00000 Drug Discovery Pre-Clinical Trials 000000 00000 00.0
0000 000 11-Sep-2020 00000 00000 0000 Drug Discovery Pre-Clinical Trials 000000 00000 00.0
00000000 000000000 09-Jul-2020 00000 00000 0000 Biotechnology Generating Revenue 000000 00000 00.0
0000000 0000000000 06-Jul-2020 00000 00000 000.00 Drug Discovery Generating Revenue 0000000 0000000 00.0
0000000 0000000000 21-May-2020 00000 00000 0000 Drug Delivery Generating Revenue 0000 0000000
0000000 0000000000 01-Apr-2020 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 0000 0000000
Design Therapeutics 06-Mar-2020 Later Stage VC 0000 Drug Discovery Generating Revenue 000000 000000 00
Arcellx 14-Oct-2019 Early Stage VC 0000 Biotechnology Pre-Clinical Trials
You’re viewing 10 of 211 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SR One Exits (115)

Company Name Exit Date Exit Type Exit Size
Avhana Health 13-Jan-2021 Merger/Acquisition
0-0000 00000000000 22-Nov-2020 0000000 000000
000000000 00000000 28-Sep-2020 000000000000000000 00.000
0000000 0000000000 17-Jul-2020 000 00000
000000 00000000000 13-Jul-2020 000 00000
0000000000 01-May-2020 0000000000
0000000 0000000 00 07-Feb-2020 000000 0000000000 000.00
0000000 0000000000 27-Dec-2019 0000000000: 000000
Progyny 25-Oct-2019 IPO 00000
Translate Bio 18-Sep-2019 Public Investment 2nd Offering 0000
You’re viewing 10 of 115 exits. Get the full list »

SR One Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

SR One Team (18)

Name Title Deals Funds Boards Office
Simeon George MD Chief Executive Officer 00 0 0 San Francisco, CA
Deborah Harland Ph.D Partner 00 0 0 London, United Kingdom
Matthew Foy Partner 0 0 0 London, United Kingdom
Karen Engel Partner, Philadelphia 0 0 Philadelphia, PA
Jill Carroll Principal 00 0 0 Philadelphia, PA
You’re viewing 5 of 18 team members. Get the full list »

SR One Co-Investors (131)

Name With Exits Lead Partner Series Industry
OrbiMed 6 0 0 Series chart Industry bar
Pfizer Ventures 0 00 Series chart Industry bar
Atlas Venture 0 0 Series chart Industry bar
Novartis Venture Fund 0 0 Series chart Industry bar
Roche Venture Fund 0 0 Series chart Industry bar
You’re viewing 5 of 131 co-investors. Get the full list »